IDELALISIB MONOTHERAPY RESULTS IN DURABLE RESPONSES IN PATIENTS WITH RELAPSED OR REFRACTORY WALDENSTROM'S MACROGLOBULINEMIA (WM)

被引：0
|
作者：
Coutre, S. [1 ]
Leonard, J. [2 ]
Flowers, C. [3 ]
Davies, A. [4 ]
Jurczak, W. [5 ]
Byrd, J. [6 ]
Spurgeon, S. [7 ]
Peterman, S.
Holes, L. [8 ]
Cho, Y. [8 ]
Sorenson, B. [8 ]
Godfrey, W. [8 ]
Gopal, A. [9 ]
机构：
[1] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[2] Weill Cornell Med Ctr, New York, NY USA
[3] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA
[4] Southampton Gen Hosp, Southampton SO9 4XY, Hants, England
[5] Malopolskie Ctr Med SC, Krakow, Poland
[6] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[7] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[8] Gilead Sci Inc, Foster City, CA 94404 USA
[9] Univ Washington, Sch Med, Seattle, WA USA
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P690
引用
下载
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [1] Idelalisib monotherapy results in durable responses in patients with relapsed or refractory Waldenstrom's macroglobulinemia (WM)
    Coutre, S.
    Leonard, J.
    Flowers, C.
    Davies, A.
    Jurczak, W.
    Byrd, J.
    Spurgeon, S.
    Peterman, S.
    Holes, L.
    Cho, Y.
    Sorenson, B.
    Godfrey, W.
    Gopal, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 102 - 102
  • [2] IDELALISIB MONOTHERAPY RESULTS IN DURABLE RESPONSES IN PATIENTS WITH RELAPSED OR REFRACTORY WALDENSTROM MACROGLOBULINEMIA
    Zinzani, P. L.
    Ghia, P.
    Coutre, S.
    Leonard, J.
    Flowers, C.
    Davies, A.
    Jurczak, W.
    Byrd, J. C.
    Spurgeon, S.
    Peterman, S.
    Holes, L.
    Cho, Y.
    Sorensen, B.
    Godfrey, W. R.
    Gopal, A. K.
    Carella, A. M.
    HAEMATOLOGICA, 2015, 100 : 38 - 39
  • [3] Idelalisib monotherapy and durable responses in patients with relapsed or refractory Waldenstroms Macroglobulinemia (WM)
    Coutre, Steven
    Leonard, John
    Flowers, Christopher
    Davies, Andrew John
    Jurczak, Wojciech
    Byrd, John C.
    Spurgeon, Stephen Edward Forbes
    Peterman, Sissy
    Holes, Leanne
    Cho, Yoonjin
    Sorenson, Bess
    Godfrey, Wayne Russell
    Gopal, Ajay K.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenstrom macroglobulinemia
    Tomowiak, Cecile
    Poulain, Stephanie
    Herbaux, Charles
    Perrot, Aurore
    Mahe, Beatrice
    Morel, Pierre
    Aurran, Therese
    Tournilhac, Olivier
    Lepretre, Stephane
    Assaad, Souad
    Villemagne, Bruno
    Casasnovas, Olivier
    Nollet, Delphine
    Roos-Weil, Damien
    Chevret, Sylvie
    Leblond, Veronique
    BLOOD ADVANCES, 2021, 5 (09) : 2438 - 2446
  • [5] BENDAMUSTINE PLUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY WALDENSTROM'S MACROGLOBULINEMIA (WM)
    Improta, S.
    Villa, M.
    Gagliardi, A.
    Lucania, A.
    Della Cioppa, P.
    Esposito, M.
    Mastrullo, L.
    HAEMATOLOGICA, 2013, 98 : 638 - 638
  • [6] DURABLE RESPONSES WITH IDELALISIB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY SMALL LYMPHOCYTIC LYMPHOMA (SLL)
    Davies, A. J.
    Gopal, A. K.
    Flinn, I. W.
    Ghia, P.
    Goy, A.
    Abella-Dominicis, E.
    Philip, B.
    Sorenson, B.
    Salles, G. A.
    Wagner-Johnston, N. D.
    HAEMATOLOGICA, 2016, 101 : 757 - 757
  • [7] Idelalisib Monotherapy and Durable Responses in Patients with Relapsed or Refractory Marginal Zone Lymphoma (MZL)
    Martin, Peter
    Armas, Armando
    Gopal, Ajay K.
    Gyan, Emmanuel
    Wagner-Johnston, Nina D.
    Walewski, Jan
    Abella, Steve
    Ye, Wei
    Philip, Betsy
    Sorenson, Bess
    de Vos, Sven
    BLOOD, 2015, 126 (23)
  • [8] Idelalisib monotherapy and durable responses in patients with relapsed or refractory small lymphocytic lymphoma (SLL)
    Gopal, A.
    Davies, A. J.
    Flinn, I.
    Ghia, P.
    Goy, A.
    Salles, G.
    Abella, S.
    Philip, B.
    Sorenson, B.
    Wagner-Johnston, N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 102 - 102
  • [9] Idelalisib monotherapy and durable responses in patients with relapsed or refractory marginal zone lymphoma (MZL)
    Martin, P.
    Armas, A.
    Gopal, A.
    Gyan, E.
    Wagner-Johnston, N.
    Walewski, J.
    Abella, S.
    Ye, W.
    Philip, B.
    Sorenson, B.
    de Vos, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 100 - 100
  • [10] Idelalisib Monotherapy and Durable Responses in Patients with Relapsed or Refractory Small Lymphocytic Lymphoma (SLL)
    Gopal, Ajay K.
    Davies, Andrew John
    Flinn, Ian W.
    Ghia, Paolo
    Goy, Andre
    Salles, Gilles A.
    Abella, Steve
    Philip, Betsy
    Sorenson, Bess
    Wagner-Johnston, Nina D.
    BLOOD, 2015, 126 (23)
12345